ReJoyce Green - Concepedia

Author

ReJoyce Green

University of California, Los Angeles ORCID

Also Known As

ReJoyce Green, Rejoyce Green

Publications

707

Citations

H-Index

Concepts

All Affiliations

University of California, Los Angeles Neurobehavioral Systems University of California San Diego Medical University of South Carolina University of Colorado Boulder

About

ReJoyce Green is an author at University of California, Los Angeles specializing in addiction, substance abuse, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	186
2	Social Sciences	3	3	64
3	Behavioral Sciences	3	3	60
4	Health Sciences	2	2	86
5	Education	1	1	16

ReJoyce Green

Publications

391

Citations

H-Index

Page 1

	Year	Citations
Effects of varenicline on subjective craving and relative reinforcing value of cigarettes ReJoyce Green, Lara A. Ray Drug and Alcohol Dependence Tobacco ControlSubstance AbuseTobacco UseAddictionMedicine	2018	64
Predictors of Substance Use Initiation by Early Adolescence ReJoyce Green, Bethany J. Wolf, Andrew Chen, American Journal of Psychiatry	2024	49
Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial Lara A. Ray, ReJoyce Green, Craig K. Enders, American Journal of Psychiatry	2021	36
Evaluation of the Addictions Neuroclinical Assessment (ANA) framework through deep phenotyping of problem drinkers Steven J. Nieto, Erica N. Grodin, ReJoyce Green, Drug and Alcohol Dependence Substance AbuseSubstance UsePsychiatryBehavioral AddictionAddiction	2021	30
The Interplay Between Subjective Response to Alcohol, Craving, and Alcohol Self‐Administration in the Human Laboratory ReJoyce Green, Erica N. Grodin, Aaron C. Lim, Alcoholism Clinical and Experimental Research	2019	26
Pain catastrophizing predicts alcohol craving in heavy drinkers independent of pain intensity Steven J. Nieto, ReJoyce Green, Erica N. Grodin, Drug and Alcohol Dependence Substance AbuseBehavioral SciencesSubstance UseHealth SciencesPsychiatry	2020	22
Do behavioral pharmacology findings predict clinical trial outcomes? A proof-of-concept in medication development for alcohol use disorder Lara A. Ray, Han Du, ReJoyce Green, Neuropsychopharmacology Substance UseSubstance Use DisordersPsychologySocial SciencesAlcohol Misuse	2020	22
Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers Daniel Roche, Spencer Bujarski, Emily E. Hartwell, Pharmacology Biochemistry and Behavior Tobacco ControlSubstance AbuseAddictionTopography IntensityNaltrexone Treatment Reduces	2015	20
Alcohol use disorder severity moderates clinical response to varenicline Suzanna Donato, ReJoyce Green, Lara A. Ray Alcoholism Clinical and Experimental Research	2021	17
Pharmacogenetic Effects of Naltrexone in Individuals of East Asian Descent: Human Laboratory Findings from a Randomized Trial Lara A. Ray, ReJoyce Green, Daniel Roche, Alcoholism Clinical and Experimental Research	2017	16

Page 1